ProCE Banner Activity

Attack-Free in HAE? Improving Disease Control and Quality of Life With New and Emerging Long-term Prophylactic Therapies


Download these slides to gain in-depth knowledge on new and emerging therapies for hereditary angioneurotic edema (HAE), including long-term prophylactics, to help patients achieve disease control and improved quality of life.

Released: May 31, 2024

Expiration: May 30, 2025



Jonathan A. Bernstein

Jonathan A. Bernstein, MD

Professor of Medicine
University of Cincinnati College of Medicine
Department of Internal Medicine
Division of Rheumatology, Allergy and Immunology
Partner Bernstein Allergy Group and Bernstein Clinical Research Center
Cincinnati, Ohio

Marc Riedl

Marc Riedl, MD, MS

Clinical Director
US HAEA Angioedema Center
Professor of Medicine
Division of Allergy & Immunology
University of California, San Diego
La Jolla, California

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner


Supported by an educational grant from Ionis Pharmaceuticals, Inc.

Ionis Pharmaceuticals, Inc.